Ultragenyx (RARE) Jumped 7.5% on FDA Approval. Can a $2.7 Million Gene Therapy Become a Commercial Success?

Reported by Yahoo Finance · Published 25 Aug 2026, 11:50 PM MYT (1 hr ago)

Summary

Source & full coverage: this summary is aggregated from Yahoo Finance, the original publisher. Read the complete report for full context, data and quotes.

Read the original report at Yahoo Finance →

Most Recent

QXO (QXO) is Rebuilding Business Models for Greater Value 1 hr ago Should You Invest in the Vanguard Total World Stock ETF? Here's My Honest Take. 1 hr ago The Family Bank: Parents Are Lending Their Kids Mortgage Money at Rates the IRS Itself Publishes, and No One Owes Gift Tax on the Discount. 1 hr ago ‘It’s the ultimate regifting’: My mom gave me a house. Should I transfer it back to her to reduce capital gains? 1 hr ago Are older Americans spoiling the economy for everyone else? 1 hr ago One Reason to Be Bullish on SanDisk Stock 1 hr ago

EconPulse

Markets. Economy. Malaysia & The World.

Independent economic news aggregation for Malaysia, Asia and global markets, updated throughout the day.

Company

About Us Editorial Standards & Corrections Privacy Policy

Work With Us

Submit a Press Release Partnerships & Advertising Contact Us RSS Feed

Contact

editor@econpulse.my

Editorial & newsroom enquiries answered within 1–2 business days.

Ultragenyx (RARE) Jumped 7.5% on FDA Approval. Can a $2.7 Million Gene Therapy Become a Commercial Success?

Summary

More in Markets

QXO (QXO) is Rebuilding Business Models for Greater Value

Should You Invest in the Vanguard Total World Stock ETF? Here's My Honest Take.

The Family Bank: Parents Are Lending Their Kids Mortgage Money at Rates the IRS Itself Publishes, and No One Owes Gift Tax on the Discount.

‘It’s the ultimate regifting’: My mom gave me a house. Should I transfer it back to her to reduce capital gains?

Are older Americans spoiling the economy for everyone else?

One Reason to Be Bullish on SanDisk Stock